These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 8016340)

  • 1. [Functional alteration of proteases and mechanisms of inhibitory action of protease inhibitors].
    Kojima S; Miura K
    Tanpakushitsu Kakusan Koso; 1994 May; 39(7):1111-20. PubMed ID: 8016340
    [No Abstract]   [Full Text] [Related]  

  • 2. Conformational homogeneity in molecular recognition by proteolytic enzymes.
    Tyndall JD; Fairlie DP
    J Mol Recognit; 1999; 12(6):363-70. PubMed ID: 10611646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteases--structures, mechanism and inhibitors.
    Powers JC; Odake S; Oleksyszyn J; Hori H; Ueda T; Boduszek B; Kam C
    Agents Actions Suppl; 1993; 42():3-18. PubMed ID: 8356929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Luminometric method for screening retroviral protease inhibitors.
    Horáková D; Rumlová M; Pichová I; Ruml T
    Anal Biochem; 2005 Oct; 345(1):96-101. PubMed ID: 16125122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of proteolysis and other posttranslational modifications with substrate-targeted inhibitors.
    Kodadek T
    Biopolymers; 2002; 66(2):134-40. PubMed ID: 12325163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Tricorn protease].
    Tamura T; Tamura N; Baumeister W
    Tanpakushitsu Kakusan Koso; 1997 Oct; 42(14 Suppl):2218-24. PubMed ID: 9366200
    [No Abstract]   [Full Text] [Related]  

  • 7. [Mechanism of action of aspartic proteases. IV.Conformational characteristics of a substrate and an inhibitor of rhizopuspepsin ].
    Kashparov IV; Popov ME; Popov EM
    Bioorg Khim; 1999 Jun; 25(6):423-34. PubMed ID: 10505230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical and molecular characterization of a detergent-stable serine alkaline protease from Bacillus pumilus CBS with high catalytic efficiency.
    Jaouadi B; Ellouz-Chaabouni S; Rhimi M; Bejar S
    Biochimie; 2008 Sep; 90(9):1291-305. PubMed ID: 18397761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Protease folding mediated by propeptides and protease inhibitors].
    Kojima S; Miura K
    Tanpakushitsu Kakusan Koso; 2001 Aug; 46(11 Suppl):1686-91. PubMed ID: 11579566
    [No Abstract]   [Full Text] [Related]  

  • 10. Functional determinants of the Epstein-Barr virus protease.
    Buisson M; Valette E; Hernandez JF; Baudin F; Ebel C; Morand P; Seigneurin JM; Arlaud GJ; Ruigrok RW
    J Mol Biol; 2001 Aug; 311(1):217-28. PubMed ID: 11469870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteases and protease inhibitors.
    Van Noorden CJ
    Acta Histochem; 1997 Aug; 99(3):245-7. PubMed ID: 9381907
    [No Abstract]   [Full Text] [Related]  

  • 12. Domain flexibility in retroviral proteases: structural implications for drug resistant mutations.
    Rose RB; Craik CS; Stroud RM
    Biochemistry; 1998 Feb; 37(8):2607-21. PubMed ID: 9485411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Designed helical peptides inhibit an intramembrane protease.
    Das C; Berezovska O; Diehl TS; Genet C; Buldyrev I; Tsai JY; Hyman BT; Wolfe MS
    J Am Chem Soc; 2003 Oct; 125(39):11794-5. PubMed ID: 14505382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protease degradomics: mass spectrometry discovery of protease substrates and the CLIP-CHIP, a dedicated DNA microarray of all human proteases and inhibitors.
    Overall CM; Tam EM; Kappelhoff R; Connor A; Ewart T; Morrison CJ; Puente X; López-Otín C; Seth A
    Biol Chem; 2004 Jun; 385(6):493-504. PubMed ID: 15255181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibiting viral proteases: challenges and opportunities.
    Bianchi E; Pessi A
    Biopolymers; 2002; 66(2):101-14. PubMed ID: 12325160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystal structure of the tricorn protease reveals a protein disassembly line.
    Brandstetter H; Kim JS; Groll M; Huber R
    Nature; 2001 Nov; 414(6862):466-70. PubMed ID: 11719810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [ICE family proteins].
    Mashima T; Tsuruo T
    Gan To Kagaku Ryoho; 1997 Sep; 24(11):1454-9. PubMed ID: 9309141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the rational design of substrate mimetics: The function of docking approaches for the prediction of protease specificities.
    Günther R; Elsner C; Schmidt S; Hofmann HJ; Bordusa F
    Org Biomol Chem; 2004 May; 2(10):1442-6. PubMed ID: 15136799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protease-catalyzed hydrolysis of substrate mimetics (inverse substrates): A new approach reveals a new mechanism.
    Thormann M; Thust S; Hofmann HJ; Bordusa F
    Biochemistry; 1999 May; 38(19):6056-62. PubMed ID: 10320331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Towards the control of intracellular protein turnover: mitochondrial Lon protease inhibitors versus proteasome inhibitors.
    Bayot A; Basse N; Lee I; Gareil M; Pirotte B; Bulteau AL; Friguet B; Reboud-Ravaux M
    Biochimie; 2008 Feb; 90(2):260-9. PubMed ID: 18021745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.